These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 12545680)

  • 21. One-year results of a pilot study using oral 13-cis retinoic acid as a treatment for subfoveal predominantly occult choroidal neovascularization in patients with age-related macular degeneration.
    Lim JI; Walonker AF; Levin L; Mahmoud M; Sadda S; Flaxel CJ; Humayun M; deJuan E; Labree L
    Retina; 2006 Mar; 26(3):314-21. PubMed ID: 16508432
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Corticosteroids as an antiangiogenic agent for histoplasmosis-related subfoveal choroidal neovascularization.
    Martidis A; Miller DG; Ciulla TA; Danis RP; Moorthy RS
    J Ocul Pharmacol Ther; 1999 Oct; 15(5):425-8. PubMed ID: 10530703
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Age related macular degeneration: a review of anti-angiogenic treatments].
    Razavi S; Coscas G; Soubrane G
    J Fr Ophtalmol; 2002 Sep; 25(7):747-52. PubMed ID: 12399735
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Anecortave acetate for the treatment of subfoveal choroidal neovascularization secondary to age-related macular degeneration.
    Schmidt-Erfurth U; Michels S; Michels R; Aue A
    Eur J Ophthalmol; 2005; 15(4):482-5. PubMed ID: 16001382
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Limited inferior macular translocation for the treatment of subfoveal choroidal neovascularization secondary to age-related macular degeneration.
    Pieramici DJ; de Juna E
    Am J Ophthalmol; 2001 Jul; 132(1):139-40. PubMed ID: 11460828
    [No Abstract]   [Full Text] [Related]  

  • 26. [Be cautious to treat choroidal neovascularization with anti-angiogenesis pharmacotherapy].
    Wei WB; Mo J
    Zhonghua Yan Ke Za Zhi; 2008 Mar; 44(3):193-5. PubMed ID: 18785539
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A 5-year follow-up study for distance visual acuity after low dose radiation on subfoveal choroidal neovascularization in age-related macular degeneration.
    Valmaggia C; Ries G; Ballinari P
    Doc Ophthalmol; 2001 Nov; 103(3):201-9. PubMed ID: 11824657
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Treatment of metastatic cancer with tetrathiomolybdate, an anticopper, antiangiogenic agent: Phase I study.
    Brewer GJ; Dick RD; Grover DK; LeClaire V; Tseng M; Wicha M; Pienta K; Redman BG; Jahan T; Sondak VK; Strawderman M; LeCarpentier G; Merajver SD
    Clin Cancer Res; 2000 Jan; 6(1):1-10. PubMed ID: 10656425
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Anecortave acetate as monotherapy for the treatment of subfoveal lesions in patients with exudative age-related macular degeneration (AMD): interim (month 6) analysis of clinical safety and efficacy.
    D'Amico DJ; Goldberg MF; Hudson H; Jerdan JA; Krueger S; Luna S; Robertson SM; Russell S; Singerman L; Slakter JS; Sullivan EK; Yannuzzi L; Zilliox P;
    Retina; 2003 Feb; 23(1):14-23. PubMed ID: 12652226
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Safety of posterior juxtascleral depot administration of the angiostatic cortisene anecortave acetate for treatment of subfoveal choroidal neovascularization in patients with age-related macular degeneration.
    Augustin AJ; D'Amico DJ; Mieler WF; Schneebaum C; Beasley C
    Graefes Arch Clin Exp Ophthalmol; 2005 Jan; 243(1):9-12. PubMed ID: 15290154
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Feeder vessel photocoagulation for subfoveal CNV.
    Freund KB; Yannuzzi LA; Spaide RF
    Ophthalmology; 1998 Dec; 105(12):2164-5. PubMed ID: 9855139
    [No Abstract]   [Full Text] [Related]  

  • 32. Macular infarction after transpupillary thermotherapy for subfoveal choroidal neovascularization in age-related macular degeneration - a possible association with systemic inflammatory disease?
    Gustavsson C; Agardh E
    Acta Ophthalmol Scand; 2004 Feb; 82(1):100-2. PubMed ID: 14738493
    [No Abstract]   [Full Text] [Related]  

  • 33. Limited inferior macular translocation for the treatment of subfoveal choroidal neovascularization secondary to age-related macular degeneration.
    D'Amico DJ; Friberg TR
    Am J Ophthalmol; 2001 Aug; 132(2):289-90. PubMed ID: 11491094
    [No Abstract]   [Full Text] [Related]  

  • 34. External beam radiation therapy for CNV.
    Chakravarthy U; Hart P; Finger P
    Ophthalmology; 1998 Oct; 105(10):1790-1; author reply 1791-2. PubMed ID: 9787339
    [No Abstract]   [Full Text] [Related]  

  • 35. Phase II trial of copper depletion with tetrathiomolybdate as an antiangiogenesis strategy in patients with hormone-refractory prostate cancer.
    Henry NL; Dunn R; Merjaver S; Pan Q; Pienta KJ; Brewer G; Smith DC
    Oncology; 2006; 71(3-4):168-75. PubMed ID: 17641535
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Thermotherapy of occult subfoveal choroidal neovascularization.
    Lanzetta P; Michieletto P
    Ophthalmology; 2001 Jun; 108(6):1011-2. PubMed ID: 11382615
    [No Abstract]   [Full Text] [Related]  

  • 37. Bone marrow-derived cells in neovascular age-related macular degeneration: contribution and potential application.
    Hou HY; Liang HL; Wang YS
    Ophthalmic Res; 2011; 45(1):1-4. PubMed ID: 20714185
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Preclinical efficacy of anecortave acetate.
    Clark AF
    Surv Ophthalmol; 2007 Jan; 52 Suppl 1():S41-8. PubMed ID: 17240256
    [TBL] [Abstract][Full Text] [Related]  

  • 39. External beam radiation therapy for CNV.
    Hawkins WR
    Ophthalmology; 1998 Oct; 105(10):1789-90. PubMed ID: 9787338
    [No Abstract]   [Full Text] [Related]  

  • 40. Foveal translocation with secondary confluent laser for subfoveal CNV in AMD: 12 month follow up.
    Wong D; Harding S; Grierson I
    Br J Ophthalmol; 2000 Jun; 84(6):670-1. PubMed ID: 10896416
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.